Streetbeat News

Price Targets

AMZN

HSBC analyst Christopher Johnen initiates coverage on Amazon.com (NASDAQ:AMZN) with a Buy rating and announces a price target of $160.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 10:10 am

MRUS

Canaccord Genuity analyst Bill Maughan has initiated coverage on Merus (NASDAQ:MRUS) with a Buy rating and a price target of $45.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 10:07 am

EYPT

Mizuho analyst Graig Suvannavejh has initiated coverage on EyePoint Pharmaceuticals (NASDAQ:EYPT) with a Buy rating and a price target of $20.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 10:02 am

MLTX

Stifel analyst Alex Thompson has initiated coverage on MoonLake (NASDAQ:MLTX) with a Buy rating and a price target of $74.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 9:57 am

ADVM

Mizuho analyst Graig Suvannavejh has initiated coverage on Adverum Biotechnologies (NASDAQ:ADVM) with a Buy rating and a price target of $2.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 9:52 am

APLS

Mizuho analyst Graig Suvannavejh has initiated coverage on Apellis Pharmaceuticals with a neutral rating and a price target of $42.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 9:49 am

EL

RBC Capital analyst Nik Modi has downgraded Estee Lauder Cos (NYSE:EL) from Outperform to Sector Perform and lowered the price target from $195 to $115.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 9:47 am

HES

Bernstein analyst Bob Brackett has downgraded Hess (NYSE:HES) from Outperform to Market Perform and lowered the price target from $189 to $166.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 9:41 am

PCOR

Jefferies analyst Brent Thill has downgraded Procore Technologies (NYSE:PCOR) from Buy to Hold and lowered the price target from $90 to $55.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 9:20 am

CHCT

Evercore ISI Group analyst Steve Sakwa has downgraded Community Healthcare (NYSE:CHCT) from Outperform to In-Line and lowered the price target from $36 to $32.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 9:13 am